Unusual Olefin Formation by PhSe-F trans-Elimination
暂无分享,去创建一个
[1] R. Schinazi,et al. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance. , 2003, Journal of medicinal chemistry.
[2] S. Shuto,et al. Nucleosides and nucleotides. Part 212: Practical large-scale synthesis of 1-(3-C-ethynyl-β-d-ribo-pentofuranosyl)cytosine (ECyd), a potent antitumor nucleoside. Isobutyryloxy group as an efficient anomeric leaving group in the Vorbrüggen glycosylation reaction ☆ , 2002 .
[3] G. A. Freeman,et al. Synthesis of Fluorosugar Analogues of 2,5,6-Trichloro-1-(β-D-ribofuranosyl)benzimidazole as Antivirals with Potentially Increased Glycosidic Bond Stability. , 2000 .
[4] L B Townsend,et al. Synthesis of fluorosugar analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole as antivirals with potentially increased glycosidic bond stability. , 2000, Journal of medicinal chemistry.
[5] J. Žemlička. Enantioselectivity of the antiviral effects of nucleoside analogues. , 2000, Pharmacology & therapeutics.
[6] V. Marquez,et al. The “β-Fluorine Effect” in the Non-Metal Hydride Radical Deoxygenation of Fluorine-Containing Nucleoside Xanthates , 2000, Nucleosides, nucleotides & nucleic acids.
[7] Raymond F. Schinazi,et al. Pharmacokinetics of the Antiviral Agent β-d-2′,3′-Didehydro-2′,3′-Dideoxy-5-Fluorocytidine in Rhesus Monkeys , 1999, Antimicrobial Agents and Chemotherapy.
[8] R. Schinazi,et al. Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosides. , 1997, Journal of Medicinal Chemistry.
[9] D. Clive,et al. Synthesis of 2′,3′-Didehydro-2′,3′-dideoxynucleosides by Reaction of 5′ -O-Protected Nucleoside 2′,3′-Dimesylates with Lithium Areneselenolates. , 1997 .
[10] Y. L. Zhu,et al. Structure‐Activity Relationships of 1‐(2‐Deoxy‐2‐fluoro‐β‐L‐ arabinofuranosyl)pyrimidine Nucleosides as anti‐Hepatitis B Virus Agents. , 1996 .
[11] E. Gullen,et al. Design and Synthesis of 2′,3′‐Dideoxy‐2′,3′‐didehydro‐β‐L‐ cytidine (β‐L‐d4C) and 2′,3′‐Dideoxy‐2′,3′‐didehydro‐β‐L‐5‐ fluorocytidine (β‐L‐Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in vitro. , 1996 .
[12] Y. L. Zhu,et al. Structure--activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents. , 1996, Journal of medicinal chemistry.
[13] E. Gullen,et al. Design and Synthesis of 2‘,3‘-Dideoxy- 2‘,3‘-didehydro-β-l-cytidine (β-l-d4C) and 2‘,3‘-Dideoxy-2‘,3‘-didehydro-β-l-5- fluorocytidine (β-l-Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in Vitro , 1996 .
[14] Soon Kil Ahn,et al. A Highly Stereoselective Synthesis of Anti‐HIV 2′,3′‐Dideoxy‐ and 2′,3′ ‐Didehydro‐2′,3′‐dideoxynucleosides. , 1992 .
[15] T. Miyasaka,et al. Selenoxide Elimination for the Synthesis of Unsaturated Sugar Uracil Nucleosides. , 1992 .
[16] T. Chou,et al. Fluorinated sugar analogues of potential anti-HIV-1 nucleosides. , 1991, Journal of medicinal chemistry.
[17] J. Chattopadhyaya,et al. SYNTHESIS OF NEW 2'-3'-MODIFIED URIDINE DERIVATIVES FROM 2',3'-ENE-2'-PHENYLSELENONYL URIDINE BY MICHAEL ADDITION REACTIONS , 1991 .
[18] R. Schinazi,et al. Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus. , 1987, Biochemical pharmacology.
[19] M. Ando,et al. A MILD AND STEREOSPECIFIC CONVERSION OF VICINAL DIOLS INTO OLEFINS VIA 2-METHOXY-1,3-DIOXOLANE DERIVATIVES , 1986 .
[20] J. G. Moffatt,et al. Reactions of 2-acyloxyisobutyryl halides with nucleosides. I. Reactions of model diols and of uridine. , 1973, Journal of the American Chemical Society.